Video
Author(s):
VistaGen Therapeutics CEO Shawn Singh discusses what he and VistaGen are doing to create and improve treatments that complement your practice.
Shawn K. Singh, JD, is the CEO of VistaGen Therapeutics, Inc.
To see more of what VistaGen is doing to improve the medicinal treatments for anxiety and depression, see Benzodiazepines Hit With Boxed Warning by FDA.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.